IL-7 R alpha & TSLP R

IL-7 R alpha & TSLP R Overview

English NameInterleukin-7 receptor subunit alphaApproved Drugs0
Drugs in Clinical Trials8Target SynonymInterleukin-7 receptor subunit alpha,Interleukin 7 Receptor Isoform H5-6,CDw127,IL-7R subunit alpha,IL-7RA,IL-7 receptor subunit alpha,CD127 Antigen,IL-7R-Alpha,Interleukin 7 Receptor Alpha Chain,CD127,IL7RA,ILRA,Interleukin-7 Receptor alpha Subunit
Highest Development StagePhase 2 Clinical
English NameInterleukin-7 receptor subunit alpha
Target SynonymInterleukin-7 receptor subunit alpha,Interleukin 7 Receptor Isoform H5-6,CDw127,IL-7R subunit alpha,IL-7RA,IL-7 receptor subunit alpha,CD127 Antigen,IL-7R-Alpha,Interleukin 7 Receptor Alpha Chain,CD127,IL7RA,ILRA,Interleukin-7 Receptor alpha Subunit
Approved Drugs0
Drugs in Clinical Trials8
Highest Development StagePhase 2 Clinical

IL-7 R alpha & TSLP R Product List

  • Product Category

    Protein (3)Cell (1)Kits (1)

  • Product Status

    Launched (5)

  • Species

    Human (4)Mouse (1)

  • Tag

    Fc Tag (3)- (2)

  • Conjugate

    Unconjugated (3)- (2)

IL-7 R alpha & TSLP R Background

TSLP is a pleiotropic cytokine originally characterized as a lymphocyte growth factor. Thymic stromal lymphopoietin (TSLP) is overexpressed in the airways of severe asthmatics and is an upstream cytokine that orchestrates inflammatory responses in asthma. Human TSLP exerts its biological activities by binding to a high-affinity heteromeric receptor complex composed of TSLPR and IL- 7 receptor and initiates signaling in cells co-expressing TSLPR and IL-7R.

IL-7 R alpha & TSLP R Synonyms

IL7Ra,CD127,TSLP R,CRLF2,IL-XR,ILXR,p2RY8,CRLF2 fusion,TSLP receptor,TSLPR,CRL2,CRLF2Y,Cytokine receptor-like 2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
CYT-107CYT-107; CYT-99-007; rhIL-7Phase 2 ClinicalRevimmune IncCarcinoma, Renal Cell; Carcinoma, Transitional Cell; Catheter-Related Infections; Coronavirus Disease 2019 (COVID-19); Hepatitis B, Chronic; Hepatitis C; HIV Infections; Kidney Neoplasms; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Lymphopenia; Metastatic breast cancer; Multiple Myeloma; Mycobacterium Infections, Nontuberculous; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neuroblastoma; Neuroectodermal Tumors, Primitive, Peripheral; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sarcoma; Sarcoma, Kaposi; Sepsis; Shock, Septic; Skin Melanoma; T-Lymphocytopenia, Idiopathic CD4-Positive; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms
Details
LusvertikimabOSE-127; S-95011; Effi-7; OSE-217Phase 2 ClinicalEffimuneColitis, Ulcerative; Sjogren's Syndrome
Details
Efineptakin alfaTJ-107; GX-I7; NT-I7Phase 2 ClinicalGannex Pharma Co LtdAstrocytoma; Breast Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Esophageal Neoplasms; Glioblastoma; Glioma; Gliosarcoma; HIV Infections; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Leukoencephalopathy, Progressive Multifocal; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphopenia; Melanoma; Multiple Myeloma; Oropharyngeal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Plasmablastic Lymphoma; Prostatic Neoplasms, Castration-Resistant; Sarcoma, Kaposi; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
Details
ASP-9801ASP-9801Phase 1 ClinicalAstellas Pharma IncNeoplasm Metastasis; Neoplasms; Solid tumours
Details
PF-06342674RN-168; PF-6342674; PF-06342674; ZB-168Phase 1 ClinicalPfizer IncDiabetes Mellitus, Type 1; Multiple Sclerosis
Details
CD19-IL7Ra CAR-T cells therapy (Chulalongkorn University)CMD-63; CMD63Phase 1 ClinicalChulalongkorn UniversityPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
Loco-regional B7H3 IL-7Ra CAR T Cell therapy(Chulalongkorn University)Phase 1 ClinicalChulalongkorn University, King Chulalongkorn Memorial HospitalBrain Neoplasms; Diffuse Intrinsic Pontine Glioma; Neoplasms; Solid tumours
Details
MDK-703MDK-703Phase 1 ClinicalMedikine IncSolid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information